Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin

Sarcopenia, Obesity and Sarcopenia Obesity in Comparison: Prevalence, Metabolic Profile, and Key Differences: Results from WCHAT Study

(2020) X. Liu et al.   Journal of Nutrition Health & Aging

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

(2020) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia

(2020) Shariff-Ghazali Sazlina et al.   PLoS One

Sarcopenia, physical frailty, undernutrition and obesity cooccurrence among Portuguese community-dwelling older adults: results from Nutrition UP 65 cross-sectional study

(2020) Ana Rita Sousa-Santos et al.   BMJ Open

Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting

(2019) Foon Yin Fung et al.   BMC Geriatrics

Metformin Delays Satellite Cell Activation and Maintains Quiescence

(2019) Theodora Pavlidou et al.   Stem Cells International

Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2

(2019) Ya Su et al.   Journal of Clinical Medicine

Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition

(2019) Fenqin Chen et al.   BMC PUBLIC HEALTH

Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies

(2018) John A. Batsis et al.   Nature Reviews Endocrinology

Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients

(2018) Yuki Fukuoka et al.   Journal of Diabetes Investigation

Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial

(2017) Doug E. Long et al.   Trials

Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older

(2017) Shan Hai et al.   BMC Geriatrics

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

(2016) Alexandra Kautzky-Willer et al.   ENDOCRINE REVIEWS

Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults

(2016) Hunkyung Kim et al.   Geriatrics & Gerontology International

Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese

(2016) Chung-Yu Huang et al.   REJUVENATION RESEARCH

Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly

(2016) Taotao Wang et al.   Scientific Reports

Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition

(2015) Peipei Han et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Hyperactive mTORC1 signaling is unaffected by metformin treatment in aged skeletal muscle

(2015) Cory M. Dungan et al.   MUSCLE & NERVE

Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)

(2014) A. J. Cruz-Jentoft et al.   AGE AND AGEING

Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia

(2014) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Incremental Predictive Value of Sarcopenia for Incident Fracture in an Elderly Chinese Cohort: Results From the Osteoporotic Fractures in Men (MrOs) Study

(2014) Ruby Yu et al.   Journal of the American Medical Directors Association

Metformin Impairs Mitochondrial Function in Skeletal Muscle of Both Lean and Diabetic Rats in a Dose-Dependent Manner

(2014) Bart Wessels et al.   PLoS One

Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases

(2014) Rita Rastogi Kalyani et al.   Lancet Diabetes & Endocrinology

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

Patients With Type 2 Diabetes Show a Greater Decline in Muscle Mass, Muscle Strength, and Functional Capacity With Aging

(2013) Marika Leenders et al.   Journal of the American Medical Directors Association

Prevalence of Sarcopenia in Community-Dwelling Japanese Older Adults

(2013) Minoru Yamada et al.   Journal of the American Medical Directors Association

Aging-Associated Reductions in Lipolytic and Mitochondrial Proteins in Mouse Adipose Tissue Are Not Rescued by Metformin Treatment

(2013) E. Mennes et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Diagnosis and Classification of Diabetes Mellitus

(2012)   DIABETES CARE

Sarcopenia in the elderly: Basic and clinical issues

(2012) Cuiying Wang et al.   Geriatrics & Gerontology International

Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With Diabetes

(2011) C. G. Lee et al.   DIABETES CARE

Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia

(2011) Roger A. Fielding et al.   Journal of the American Medical Directors Association

Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats

(2010) Daniel A. Kane et al.   FREE RADICAL BIOLOGY AND MEDICINE

Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes

(2009) S. W. Park et al.   DIABETES CARE

Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives

(2008) Y. Rolland et al.   Journal of Nutrition Health & Aging